|
|
| NDC Number | Brand Name | Generic Name | Labeler | Dosage Form | DEA Schedule | Marketing Start Date |
|---|---|---|---|---|---|---|
| 0006-5073 | ENFLONSIA | CLESROVIMAB | Merck Sharp & Dohme LLC | INJECTION, SOLUTION | 2025-06-09 | |
| 49281-574 | BEYFORTUS | nirsevimab | Sanofi Pasteur Inc. | INJECTION | 2023-07-18 | |
| 49281-575 | BEYFORTUS | nirsevimab | Sanofi Pasteur Inc. | INJECTION | 2023-07-18 | |
| 66658-230 | Synagis | palivizumab | Swedish Orphan Biovitrum AB (publ) | INJECTION, SOLUTION | 1999-12-09 | |
| 66658-231 | Synagis | palivizumab | Swedish Orphan Biovitrum AB (publ) | INJECTION, SOLUTION | 1998-06-19 |
Loading full table content...